Figure 4.
Cumulative incidences of categorized SMN subtypes by PSH method. (A) Second female breast cancer, (B) SMN in the digestive system, (C) SMN in genital system, (D) SMN in the respiratory system, (E) SMN in the skin, (F) SMN in the endocrine system, (G) SMN in the urinary system, (H) SMN in the oral cavity and pharynx, (I) other second solid tumors, (J) second NHL, (K) second leukemia, and (L) other second hematologic malignancy. SMN, second malignant neoplasm; PSH, proportional subdistribution hazard; NHL, non-Hodgkin lymphoma.